b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30802561</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>20</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1097-6787</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>81</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Aug</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of the American Academy of Dermatology</Title>\n                <ISOAbbreviation>J. Am. Acad. Dermatol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>558-567</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0190-9622(19)30338-X</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2019.02.047</ELocationID>\n            <Abstract>\n                <AbstractText>Radiation dermatitis is a\xc2\xa0common sequela of radiation therapy; up to 95% of patients will develop moderate-to-severe skin reactions. No criterion standard currently exists for the treatment of acute radiation-induced skin toxicity. It is therefore imperative to develop a greater understanding of management options available to allow clinicians to make informed decisions when managing radiation oncology patients. This literature review discusses the topical agents that have been studied for the treatment of acute radiation dermatitis, reviews their mechanisms of action, and presents a treatment algorithm for clinicians managing patients experiencing radiation dermatitis.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Rosenthal</LastName>\n                    <ForeName>Amanda</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>University of Miami Miller School of Medicine, Miami, Florida; Moy-Fincher-Chipps Facial Plastics &amp; Dermatology, Beverly Hills, California. Electronic address: ahr52@med.miami.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Israilevich</LastName>\n                    <ForeName>Rachel</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Moy-Fincher-Chipps Facial Plastics &amp; Dermatology, Beverly Hills, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Moy</LastName>\n                    <ForeName>Ronald</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Moy-Fincher-Chipps Facial Plastics &amp; Dermatology, Beverly Hills, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>22</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Am Acad Dermatol</MedlineTA>\n            <NlmUniqueID>7907132</NlmUniqueID>\n            <ISSNLinking>0190-9622</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000891">Anti-Infective Agents, Local</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001688">Biological Products</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D003879">Dermatologic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D004983">Ethanolamines</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D028321">Plant Preparations</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014815">Vitamins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>54182-58-0</RegistryNumber>\n                <NameOfSubstance UI="D013392">Sucralfate</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9O3K93S3TK</RegistryNumber>\n                <NameOfSubstance UI="C009546">triethanolamine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>W46JY43EJR</RegistryNumber>\n                <NameOfSubstance UI="D012837">Silver Sulfadiazine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000891" MajorTopicYN="N">Anti-Infective Agents, Local</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001458" MajorTopicYN="N">Bandages</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003879" MajorTopicYN="N">Dermatologic Agents</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004983" MajorTopicYN="N">Ethanolamines</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D028321" MajorTopicYN="N">Plant Preparations</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011855" MajorTopicYN="N">Radiodermatitis</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012837" MajorTopicYN="N">Silver Sulfadiazine</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013392" MajorTopicYN="N">Sucralfate</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">aloe vera</Keyword>\n            <Keyword MajorTopicYN="N">ascorbic acid</Keyword>\n            <Keyword MajorTopicYN="N">calendula</Keyword>\n            <Keyword MajorTopicYN="N">catechins</Keyword>\n            <Keyword MajorTopicYN="N">chamomile</Keyword>\n            <Keyword MajorTopicYN="N">corticosteroids</Keyword>\n            <Keyword MajorTopicYN="N">dermatitis</Keyword>\n            <Keyword MajorTopicYN="N">epidermal growth factor</Keyword>\n            <Keyword MajorTopicYN="N">granulocyte macrophage-colony stimulating factor</Keyword>\n            <Keyword MajorTopicYN="N">hyaluronic acid</Keyword>\n            <Keyword MajorTopicYN="N">management</Keyword>\n            <Keyword MajorTopicYN="N">pantothenic acid</Keyword>\n            <Keyword MajorTopicYN="N">prevention</Keyword>\n            <Keyword MajorTopicYN="N">radiation</Keyword>\n            <Keyword MajorTopicYN="N">radiation dermatitis</Keyword>\n            <Keyword MajorTopicYN="N">radiation oncology</Keyword>\n            <Keyword MajorTopicYN="N">radiation-induced skin toxicity</Keyword>\n            <Keyword MajorTopicYN="N">radiotherapy</Keyword>\n            <Keyword MajorTopicYN="N">silver clear nylon dressing</Keyword>\n            <Keyword MajorTopicYN="N">silver sulfadiazine</Keyword>\n            <Keyword MajorTopicYN="N">statins</Keyword>\n            <Keyword MajorTopicYN="N">steroids</Keyword>\n            <Keyword MajorTopicYN="N">sucralfate</Keyword>\n            <Keyword MajorTopicYN="N">topical</Keyword>\n            <Keyword MajorTopicYN="N">topical agents</Keyword>\n            <Keyword MajorTopicYN="N">treatment</Keyword>\n            <Keyword MajorTopicYN="N">trolamine</Keyword>\n            <Keyword MajorTopicYN="N">washing</Keyword>\n            <Keyword MajorTopicYN="N">\xce\xb2-sitosterol</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30802561</ArticleId>\n            <ArticleId IdType="pii">S0190-9622(19)30338-X</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jaad.2019.02.047</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'